menu Home

Program

  • DAY 1 / March 7(Fri)
  • DAY 2 / March 8(Sat)

DAY 1 / March 7(Fri). 2025

Grand Auditorium (B1), Seoul St. Mary's Hospital, Seoul, Korea

Master of Ceremonies: Seo Yeon LEE (Korea)

Time Program Chair / Speaker
12:00-13:00 Board Meeting
13:00-13:10 Opening Remarks Sung Kyu HONG (President, KPS)
Seong Il SEO (President, KUA)
13:10-14:10 Session I: Management of Biochemical Recurrence: A New Era Unfolds? Seong Il SEO (Korea)
Kuan Chou CHEN (Taiwan)
13:10-13:20 Application of Next-generation Imaging in Biochemically Recurrent Prostate Cancer Dongho SHIN (Korea)
13:20-13:30 Salvage Treatment: to Whom or Not to Whom? Seyun KWON (Korea)
13:30-13:40 Could ARSi Be A New Treatment Option for Some Patients? Se Young CHOI (Korea)
13:40-14:10 Case-Based Panel Discussion Tae Hyo KIM (Korea)
Jae Seung CHUNG (Korea)
Sungchan PARK (Korea)
14:10-14:30 Satellite Symposium #1 - NOVARTIS Sung Kyu HONG (Korea)
Advancing Radioligand Therapy in Prostate Cancer: Lessons from Clinical Practice Dong Yun LEE (Korea)
14:30-15:50 Session II: Navigating Management of Active Surveillance for Prostate Cancer Taek Won KANG (Korea)
Bannakij LOJANAPIWAT (Thailand)
14:30-14:50 Opportunities to Expand and Improve AS for Localized Prostate Cancer John W. DAVIS (USA)
14:50-15:00 Is Serial MRI A Reliable Method to Detect Progression during AS? Joongwon CHOI (Korea)
15:00-15:20 Role of Confirmatory Biopsies and PSMA PET for Active Surveillance of Low Risk Prostate Cancer Nathan LAWRENTSCHUK (Australia)
15:20-15:30 AS: Criteria, Schedule, and When to Stop Jeong Woo LEE (Korea)
15:30-15:50 Panel Discussion Hyun Chul CHUNG (Korea)
Jong Hyun YOON (Korea)
Yun Beom KIM (Korea)
15:50-16:10 Coffee Break
16:10-17:50 Session III: A New Approach for mHSPC - Who Are The Ideal Candidates? Kyung Seop LEE (Korea)
Seok Joong YUN (Korea)
Debate - What Are The Ideal Treatment Options
16:10-16:20 1. Doublet Therapy Is Sufficient Taek Sang KIM (Korea)
16:20-16:30 2. Triplet Therapy Is The Preferred Approach Jong Kil NAM (Korea)
16:30-16:50 The Evolving Management of Oligometastatic Prostate Cancer David F. JARRARD (USA)
16:50-17:10 De-intensification in Good Responders: Cons vs. Pros Patrick G. PILIÉ (USA)
17:10-17:30 Degarelix: GnRH Antagonist for Advanced Hormone-dependent Prostate Cancer Haruna KAWANO (Japan)
17:30-17:50 Case-Based Panel Discussion Gyeong Eun MIN (Korea)
Jae Duck CHOI (Korea)
Yun-Sok HA (Korea)
Sang Wook LEE (Korea)
17:50 Welcome Dinner  

DAY 2 / March 8(Sat). 2025

Convention Hall, Omnibus Park, Songeui Campus, Catholic University of Korea, Seoul, Korea

Master of Ceremonies: U-Syn HA (Korea)

Time Program Chair / Speaker
08:30-09:30 Podium Session (Non-Moderated)
09:30-10:30 Session IV: How to Best Approaches to Prostate Cancer Patients in Locally Advanced Disease Moon Ki JO (Korea)
Jun Hyuk HONG (Korea)
09:30-09:40 RP as Local Treatment Byung Hoon KIM (Korea)
09:40-09:50 RT as Local Treatment See Min CHOI (Korea)
09:50-10:00 How to Select and Treat Patients for Adjuvant Therapy after RP Seong Hyeon YU (Korea)
10:00-10:30 Case-Based Panel Discussion Soodong KIM (Korea)
Dalsan YOU (Korea)
Sang Hun SONG (Korea)
10:30-10:50 Satellite Symposium #2 - ASTELLAS Sung Kyu HONG (Korea)
The Importance of Early Intensificstion and First Treatment Choice in mHSPC Hyunho HAN (Korea)
10:50-11:10 Coffee Break
11:10-12:30 Session V: Recent Advances in Prostate Cancer Screening and Staging Tag Keun YOO (Korea)
Jun Sung KOH (Korea)
Prostate Biopsy: Which Method Should Be Preferred?
11:10-11:20 1. Transperineal Jong Wook KIM (Korea)
11:20-11:30 2. Transrectal Jae Hyun RYU (Korea)
11:30-11:40 Persistent Elevated PSA Despite Normal Tissue Biopsy: Clinical Management Strategies Hakmin LEE (Korea)
11:40-12:00 Clinical Utilisation of PSMA-PET: Current Utilisation for Staging of Prostate Cancer Nathan LAWRENTSCHUK (Australia)
12:00-12:30 Panel Discussion Chang Hee YOO (Korea)
Hwang Gyun JEON (Korea)
Hongzoo PARK (Korea)
Yu Seob SHIN (Korea)
12:30-13:00 Special Lecture Sung Kyu HONG (Korea)
27 Years in Urology, 15 Years with KPS: A Journey of Expertise and Commitment
- Part 1
Seong Il SEO (Korea)
13:00-14:00 Luncheon Symposium and Lunch - JANSSEN Sung Kyu HONG (Korea)
Starting Treatment with Apalutamide in mHSPC all Comer Patients Jongwook PARK (Korea)
14:00-15:20 Session VI: Treatment Strategies for mCRPC in The Era of ARSi as Standard of Care for mHSPC Jae-Young JOUNG (Korea)
Paksi SATYAGRAHA (Indonesia)
14:00-14:10 Ideal Sequence after ADT Plus ARSi Jae Young PARK (Korea)
14:10-14:20 PSMA-Based Therapy Jongsoo LEE (Korea)
14:20-14:40 Combination Therapies in Metastatic Prostate Cancer" (e.g PARP Inhibition and ARSi) Patrick G. PILIÉ (USA)
14:40-15:00 Manipulating the Androgen Axis: New Agents in mHSPC and CRPC David F. JARRARD (USA)
15:00-15:20 Case-Based Panel Discussion Won Tae KIM (Korea)
Sangchul LEE (Korea)
Hyunho HAN (Korea)
15:20-15:40 Coffee Break
15:40-17:00 Session VII: Tips and Tricks for RARP and BPH Surgery Ji Youl LEE (Korea)
Kyung Hyun MOON (Korea)
15:40-16:00 RARP: Tips and Tricks for Challenging Cases-the Expected and The Surprises John W. DAVIS (USA)
16:00-16:20 Convective Water Vapor Therapy(Rezum) as a Minimally Invasive Treatment for BPH Byoung Kyu HAN (Korea)
16:20-16:40 Robotic Simple Prostatectomy for Huge Prostate Sang Hoon SONG (Korea)
16:40-17:00 Panel Discussion Hong Seok SHIN (Korea)
Hyoung Keun PARK (Korea)
Phil Hyun SONG (Korea)
17:00-17:20 General Assembly
17:20-17:25 Closing Remark Sung Kyu HONG (President, KPS)
go to top

Copyright(C) by 2025 KPS Annual Prostate International Meeting.
All rights reserved.

Secretariat of KPS

Gaon Convention Services, Inc.
ADDRESS: ROOM 1005, 228, Gonghang-daero, Gangseo-gu, Seoul, Republic of Korea.
TEL : +82-2-6956-7989   |   E-MAIL : gaonpco@gaonpco.com

close

사전등록

등록구분
근무처
소속의사회

* 의사 회원인 경우에는 연수평점 카드 기록을 위해서 필요 합니다.